inclusion criteria: * 1 - acute symptoms compatible with sars-cov-2 infection: fever, cough, myalgia, dysgeusia / ageusia, dyspnea, pulmonary infiltrates on x-ray / ct, or any sign / symptom attributable to said infection * 2. microbiologically confirmed infection by sars-cov-2 (pcr and / or clia or elisa serology or with a valid microbiological diagnostic test with antigen test). * 3.\> 18 years. * 4. \<2 weeks from the onset of symptoms. * 5. admitted (with or without pneumonia) and ambulant (with pneumonia demonstrated by x-ray or ct) * 6. some analytical degree of moderate inflammation defined by pcr between 20 and 80 mg / l and / or ferritin between the high limit of normality (lan) and 3 times said lan * 7. signing of the informed consent, or acceptance of oral consent before witnesses.

inclusion criteria: * 1 - acute symptoms compatible with sars-cov-2 infection: fever, cough, myalgia, dysgeusia / ageusia, dyspnea, pulmonary infiltrates on x-ray / ct, or any sign / symptom attributable to said infection * 2. microbiologically confirmed infection by sars-cov-2 (pcr and / or clia or elisa serology or with a valid microbiological diagnostic test with antigen test). * 3.\> 18 years. * 4. \<2 weeks from the onset of symptoms. * 5. admitted (with or without pneumonia) and ambulant (with pneumonia demonstrated by x-ray or ct) * 6. some analytical degree of moderate inflammation defined by pcr between 20 and 80 mg / l and / or ferritin between the high limit of normality (lan) and 3 times said lan * 7. signing of the informed consent, or acceptance of oral consent before witnesses.

inclusion criteria: - 1 - acute symptoms compatible with sars-cov-2 infection: fever, cough, myalgia, dysgeusia / ageusia, dyspnea, pulmonary infiltrates on x-ray / ct, or any sign / symptom attributable to said infection - 2. microbiologically confirmed infection by sars-cov-2 (pcr and / or clia or elisa serology or with a valid microbiological diagnostic test with antigen test). - 3.> 18 years. - 4. <2 weeks from the onset of symptoms. - 5. admitted (with or without pneumonia) and ambulant (with pneumonia demonstrated by x-ray or ct) - 6. some analytical degree of moderate inflammation defined by pcr between 20 and 80 mg / l and / or ferritin between the high limit of normality (lan) and 3 times said lan - 7. signing of the informed consent, or acceptance of oral consent before witnesses.

inclusion criteria: - 1 - acute symptoms compatible with sars-cov-2 infection: fever, cough, myalgia, dysgeusia / ageusia, dyspnea, pulmonary infiltrates on x-ray / ct, or any sign / symptom attributable to said infection - 2. microbiologically confirmed infection by sars-cov-2 (pcr and / or clia or elisa serology or with a valid microbiological diagnostic test with antigen test). - 3.> 18 years. - 4. <2 weeks from the onset of symptoms. - 5. admitted (with or without pneumonia) and ambulant (with pneumonia demonstrated by x-ray or ct) - 6. some analytical degree of moderate inflammation defined by pcr between 20 and 80 mg / l and / or ferritin between the high limit of normality (lan) and 3 times said lan - 7. signing of the informed consent, or acceptance of oral consent before witnesses.